Delaying treatment for CIN 2 does not increase three-year cervical cancer risk, study finds
Medical Xpress1 min read74 words
A target trial emulation study found that among women with cervical intraepithelial neoplasia (CIN) grade 2 (CIN 2), a moderate form of precancerous cervical dysplasia, excision within six months did not lower three-year cervical cancer risk compared with continued surveillance. Delaying treatment substantially reduced unnecessary cervical excisions. These observations suggest that it may be safe to delay treatment of CIN 2, especially lower-risk CIN 2. The findings are published in Annals of Internal Medicine.
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.